These authors found that only one—the ERCC1 isoform 202—out of four ERCC1 isoforms had a full functional capacity in NER and could be associated with cisplatin resistance in NSCLC [31]. The gene discussed is ERCC1; the disease is non-small cell lung carcinoma.